Trade Secrets. The Company and its Subsidiaries have taken reasonable and customary actions to protect their rights in and prevent the unauthorized use and disclosure of trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its Subsidiaries, and, there has been no unauthorized use or disclosure of the trade secrets or confidential business information.
Appears in 28 contracts
Sources: Placement Agency Agreement (Vivani Medical, Inc.), Atm Sales Agreement (Vision Marine Technologies Inc.), Placement Agency Agreement (BriaCell Therapeutics Corp.)
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their its rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 5 contracts
Sources: Underwriting Agreement (Elevation Oncology, Inc.), Underwriting Agreement (Alzamend Neuro, Inc.), Sales Agreement (Passage BIO, Inc.)
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their its rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including which may include confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the material trade secrets or and confidential business information.
Appears in 4 contracts
Sources: Underwriting Agreement (Edgewise Therapeutics, Inc.), Underwriting Agreement (Edgewise Therapeutics, Inc.), Underwriting Agreement (Edgewise Therapeutics, Inc.)
Trade Secrets. The Company and its Subsidiaries subsidiaries have taken reasonable and customary actions to protect their its rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including which may include confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the material trade secrets or and confidential business information.
Appears in 4 contracts
Sources: Common Stock Sales Agreement (Edgewise Therapeutics, Inc.), Common Stock Sales Agreement (Edgewise Therapeutics, Inc.), Common Stock Sales Agreement (Edgewise Therapeutics, Inc.)
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, to the Company’s Knowledge, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 3 contracts
Sources: Securities Purchase Agreement (Adlai Nortye Ltd.), Securities Purchase Agreement (Adlai Nortye Ltd.), Securities Purchase Agreement (CARGO Therapeutics, Inc.)
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their its rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including which may include confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 2 contracts
Sources: Underwriting Agreement (BioAtla, Inc.), Underwriting Agreement (BioAtla, Inc.)
Trade Secrets. The Company and its Subsidiaries subsidiaries have taken reasonable and customary actions to protect their rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposalsplans) owned by the Company and its Subsidiariessubsidiaries, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 2 contracts
Sources: Underwriting Agreement (NantKwest, Inc.), Underwriting Agreement (NantKwest, Inc.)
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their its rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including which may include confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the material trade secrets or and confidential business information.
Appears in 2 contracts
Sources: Underwriting Agreement (Oric Pharmaceuticals, Inc.), Underwriting Agreement (Oric Pharmaceuticals, Inc.)
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its Subsidiaries, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 2 contracts
Sources: Underwriting Agreement (Precision Biosciences Inc), Underwriting Agreement (Precision Biosciences Inc)
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their its rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including material confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, to the knowledge of the Company, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 1 contract
Sources: Securities Purchase Agreement (Kura Oncology, Inc.)
Trade Secrets. The Company and its Subsidiaries subsidiaries have taken reasonable and customary actions to protect their its rights in and to prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its Subsidiariessubsidiaries, and, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 1 contract
Sources: Atm Equity Offering Sales Agreement (Septerna, Inc.)
Trade Secrets. The Company and its Subsidiaries subsidiaries have taken reasonable and customary actions to protect their rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its Subsidiariessubsidiaries, and, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 1 contract
Trade Secrets. The Company and its Subsidiaries have has taken reasonable and customary actions to protect their its rights in and to prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost information, business and marketing plans and proposals) owned by the Company and its SubsidiariesCompany, and, there has been no unauthorized use or disclosure of the trade secrets or confidential business informationdisclosure.
Appears in 1 contract